Yang and colleagues suggested that the oncosuppressive role of miR-223 in breast cancer is also exerted through the targeting of stromal interaction molecule1 (STIM1), a known oncoprotein and calcium sensor protein in the endoplasmic reticulum which is involved in breast cancer progression and metastasization [136]. Here, LRP2 is linked to breast carcinoma.